But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

In addition to receiving treatment, there are lifestyle changes you can make to help manage the symptoms of end-stage COPD. Maintaining your quality of life is very important during end-stage COPD.

Looking ahead, more therapies are needed for the treatment of early COPD, as well as therapies that can be administered to a large number of patients at a reasonable cost, Mannino added.

In stable COPD patients, long-term treatment with ... Although these exacerbations can be treated acutely with antibiotics or steroids, it would be useful to have other treatments that reduced ...